Previous studies have indicated that the disorder of immune cells (Treg and Th17 cells) in fatty liver disease may be regulated by microRNA-29c by acting on the FOS gene, thereby regulating liver damage and fat deposition. This evidence concerns the gene FOS and fatty liver disease.